- Home
- ZTO vs EXEL Comparison
ZTO vs EXEL Comparison
Compare ZTO & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTO
- EXEL
- Stock Information
- Founded
- ZTO 2002
- EXEL 1994
- Country
- ZTO China
- EXEL United States
- Employees
- ZTO N/A
- EXEL N/A
- Industry
- ZTO Advertising
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZTO Consumer Discretionary
- EXEL Health Care
- Exchange
- ZTO Nasdaq
- EXEL Nasdaq
- Market Cap
- ZTO 13.4B
- EXEL 12.0B
- IPO Year
- ZTO 2016
- EXEL 2000
- Fundamental
- Price
- ZTO $20.59
- EXEL $37.72
- Analyst Decision
- ZTO Buy
- EXEL Buy
- Analyst Count
- ZTO 5
- EXEL 21
- Target Price
- ZTO $22.64
- EXEL $44.00
- AVG Volume (30 Days)
- ZTO 2.2M
- EXEL 3.7M
- Earning Date
- ZTO 08-19-2025
- EXEL 07-28-2025
- Dividend Yield
- ZTO 3.40%
- EXEL N/A
- EPS Growth
- ZTO N/A
- EXEL 81.76
- EPS
- ZTO 1.22
- EXEL 2.08
- Revenue
- ZTO $6,230,576,589.00
- EXEL $2,230,005,000.00
- Revenue This Year
- ZTO $15.10
- EXEL $9.88
- Revenue Next Year
- ZTO $11.79
- EXEL $12.59
- P/E Ratio
- ZTO $16.97
- EXEL $18.17
- Revenue Growth
- ZTO 14.76
- EXEL 10.73
- 52 Week Low
- ZTO $16.34
- EXEL $25.12
- 52 Week High
- ZTO $27.50
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- ZTO 62.80
- EXEL 36.91
- Support Level
- ZTO $19.58
- EXEL $36.37
- Resistance Level
- ZTO $20.85
- EXEL $38.09
- Average True Range (ATR)
- ZTO 0.38
- EXEL 1.27
- MACD
- ZTO 0.04
- EXEL -0.50
- Stochastic Oscillator
- ZTO 85.44
- EXEL 17.44
About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 22.1% in 2022. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 77% voting rights as of June 30, 2023. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 11.7% interest.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.